Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Medical Genetics Laboratory, |
RCV001256188 | SCV001423821 | pathogenic | Autosomal recessive axonal neuropathy with neuromyotonia | criteria provided, single submitter | research | A homozygous missense variant of c.355C>T (p.His119Trp) was identified in the HINT1 gene in a patient affected with axonal neuropathy with neuromyotonia, which was confirmed as having been transmitted from the parents. The p.His119 site is highly conserved during evolution. The SIFT, Polyphen-2 and Provean softwares predict that the variant is damaging. | |
Labcorp Genetics |
RCV001256188 | SCV002141892 | uncertain significance | Autosomal recessive axonal neuropathy with neuromyotonia | 2020-12-01 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs768248277, ExAC 0.009%). This sequence change replaces arginine with tryptophan at codon 119 of the HINT1 protein (p.Arg119Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant has been observed in individual(s) with clinical features of myotonia (PMID: 31400136). ClinVar contains an entry for this variant (Variation ID: 978220). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |